Research Articles | Page 19 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes May 2014 Leukemia myelodysplastic syndromes (MDS)
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Diagnostic algorithm for lower-risk myelodysplastic syndromes Jun 2018 Leukemia myelodysplastic syndromes (MDS)
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents Dec 2015 Leuk Res. myelodysplastic syndromes (MDS)
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia Apr 2017 Leuk Res Rep
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes Jul 2014 Leuk Res Rep myelodysplastic syndromes (MDS)
Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis May 2015 Leuk Res Rep paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.